XOMA Royalty Corporation (XOMA) Stock Analysis

Free AI-powered analysis and research for XOMA Royalty Corporation stock

Sector: Healthcare

Analyze XOMA Royalty Corporation (XOMA) Stock

XOMA Royalty Corporation (XOMA) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into XOMA stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for XOMA Royalty Corporation stock.

Analyze XOMA Now →

📰 Latest Update

Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal

Mon, April 27, 2026 at 8:11 PM UTC 2 min read

XOMA Corporation has entered into a significant partnership with Ligand Pharmaceuticals in a $739 million deal, aimed at enhancing their royalty-generating capabilities. This collaboration is expected to bolster XOMA's financial position and expand its portfolio, which may attract investor interest due to the potential for increased revenue streams. The deal underscores the growing trend of strategic alliances in the biotech sector, positioning XOMA favorably in a competitive market.

Read full article →